Gts Securities LLC Gilead Sciences, Inc. Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$66.59 - $83.99 $159,816 - $201,576	2,400 Added 3.37%	73,600 $6.17 Million
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $2.21 Million - $2.55 Million	35,000 Added 96.69%	71,200 $4.89 Million
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $2.68 Million - $3.26 Million	-37,400 Reduced 50.82%	36,200 $2.65 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $2.9 Million - $3.29 Million	-39,600 Reduced 34.98%	73,600 $5.96 Million
Q3 2023 Nov 15, 2023	BUY	$73.94 - $80.67 $8.37 Million - $9.13 Million	113,200 New	113,200 $8.48 Million

1,926

992M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.